共 12 条
[1]
RRM1 mRNA and PTEN asprognostic parameters for overall and disease-free survival in patientswith non-small-cell lung cancer. Bepler G,Sharma S,Cantor A,et al. Journal of Clinical Oncology . 2004
[2]
Ribonucleotide reductase: an old target with new potential[J] . B.Douglas Smith,Judith E. Karp.  Leukemia Research . 2003 (12)
[3]
Gene expression asa predictive marker of outcome in stageⅡB-ⅢA-ⅢB non-small cell lung cancer after induction gemcitabine-based chemo-therapy followed by resectional surgery. ROSELL R,FELIP E,TARON M,et al. Clinical Cancer Research . 2004
[4]
How could pharmacogenomics help improve patient survival?[J] . Rafael Rosell,Enriqueta Felip,Luis Paz-Ares.  Lung Cancer . 2007
[5]
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Rosell R,Danenberg KD,Alberola V,et al. Clinical Cancer Research . 2004
[6]
Ribonucleotide reductase:an old target with new potential. Smith B D,Karp J E. Leukemia Research . 2003
[7]
Biomarkers with predictive and prognostic function in non-small cell lung cancer:ready for prime time. Aggarwal C,Somaiah N,Simon GR,et al. J Natl Compr Canc Netw . 2010
[10]
RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum[J]. Lin-run WANG, Guo-bing ZHANG, Jian CHEN, Jun LI, Ming-wei LI, Nong XU, Yang WANG, Jian-zhong SHEN TU. Journal of Zhejiang University-Science B(Biomedicine & Biotechnology). 2012(11)